Targretin Coupons & Savings Card – Discount Prices from $750.60

Targretin is used for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have not responded well to other systemic therapies.

Bexarotene is not classified as traditional chemotherapy. It is a retinoid, which is a type of medication related to vitamin A, and is used primarily to treat cutaneous T-cell lymphoma.

When taking bexarotene, it is advisable to avoid grapefruit and grapefruit juice. Grapefruit can interfere with the metabolism of the medication, potentially leading to increased levels in the blood and a higher risk of side effects. It is also important to follow any specific dietary recommendations provided by a healthcare provider.

Targretin (bexarotene) is considered effective for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who are refractory to at least one prior systemic therapy. Its effectiveness can vary among individuals, and it is typically evaluated based on the reduction of skin lesions and improvement in symptoms. Clinical trials have shown that a significant number of patients experience a partial or complete response to the treatment. However, the effectiveness can depend on various factors, including the stage of the disease and the patient's overall health. It is important for patients to discuss their specific case with their healthcare provider to understand how Targretin may work for them.

Targretin (bexarotene) works by selectively binding to and activating retinoid X receptors (RXRs). These receptors are involved in regulating gene expression that controls cell growth, differentiation, and apoptosis. By activating RXRs, Targretin can inhibit the growth of certain cancer cells, particularly in cutaneous T-cell lymphoma (CTCL).